This page follows insider dealings at Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) as filed with SEDI. Nothing new has been filed by managers of Edesa Biotech, Inc. (formerly Stellar Biotechnologies, Inc.) in twelve months, the latest record being from 22 September 2020.
The full history, which starts in 2019, counts 7 purchases against 1 sale.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 39 declarations
Edesa Biotech, Inc. is a biopharmaceutical company focused on developing treatments for immunological and dermatological diseases. It was previously known as Stellar Biotechnologies, Inc.